VCM
ASXC

Versant Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Versant Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15
Closed – – 1563
2016
Q3 		$0 Buy
+15
New +$274 ﹤0.01% 1520

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Versant Capital Management's ASXC Position: Q4 2016 in Review

Versant Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2016, closing a stake of 15 shares.

Versant Capital Management first reported a position in ASXC in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 87 funds tracked by Wall St. Rank hold ASXC as of Q4 2016.

  • Versant Capital Management reported no remaining Asensus Surgical, Inc. position as of Q4 2016 after selling out during the quarter.
  • Versant Capital Management sold 15 Asensus Surgical, Inc. shares in Q4 2016.
  • Versant Capital Management first reported a position in Asensus Surgical, Inc. in Q3 2016 and held it in 1 quarter.
  • Versant Capital Management's Asensus Surgical, Inc. position peaked at $0 in Q3 2016.
  • 87 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2016.

Based on Versant Capital Management's 13F filing for Q4 2016, filed 23 Apr 2018.